HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Related articles in AJPH Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marks, H M Search for Related Content PubMed PubMed Citation Articles by Marks, H M

Revisiting "the origins of compulsory drug prescriptions".

H M Marks

Department of the History of Science, Medicine and Technology, Johns Hopkins University, Baltimore, Md. 21205.

It has been argued that today's prescription drug market originated in the arbitrary acts of the US Food and Drug Administration (FDA), which in 1938 issued regulations creating a class of drugs that could be sold by prescription only. On the basis of the FDA's administrative records, I argue that the 1938 regulations on prescription drug labeling were initiated by industry and then agreed to by the FDA; that contemporaries understood and accepted the reasons for restricting the use of certain drugs; and that the subsequent evolution of these regulations is best understood as an FDA effort to limit industry abuses of the prescription labeling system. This decade-long war of position ended when drug manufacturers persuaded the US Congress to enshrine their version of prescription labeling in law in a highly politicized struggle over government's role in the economy.

Related articles in AJPH:

Drug regulation and drug information--who should do what to whom?

J Avorn
AJPH 1995 85: 18-19. [PDF]  

This article has been cited by other articles:

				J. Abraham and C. Davis Deficits, Expectations and Paradigms in British and American Drug Safety Assessments: Prising Open the Black Box of Regulatory Science Science Technology Human Values, July 1, 2007; 32(4): 399 - 431. [Abstract] [PDF]

				J. A. Greene Pharmaceutical Marketing Research and the Prescribing Physician Ann Intern Med, May 15, 2007; 146(10): 742 - 748. [Abstract] [Full Text] [PDF]